In our study, alterations in MLL2 were overall associated with a poor response to ICIs in TMB-H solid tumors, suggesting that the response to ICI in the presence of MLL2 alterations varies according to tumor type or MLL2 alteration type. The gene discussed is KMT2B; the disease is neoplasm.